NIM
Needham Investment Management’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $521K | Sell |
434,435
-100,000
| -19% | -$120K | 0.04% | 141 |
|
|
2025
Q1 | $577K | Sell |
534,435
-200,000
| -27% | -$216K | 0.05% | 138 |
|
|
2024
Q4 | $1.29M | Sell |
734,435
-50,000
| -6% | -$87.5K | 0.1% | 124 |
|
|
2024
Q3 | $1.51M | Sell |
784,435
-200,000
| -20% | -$386K | 0.12% | 116 |
|
|
2024
Q2 | $1.74M | Sell |
984,435
-140,000
| -12% | -$248K | 0.14% | 113 |
|
|
2024
Q1 | $3.05M | Hold |
1,124,435
| – | – | 0.28% | 85 |
|
|
2023
Q4 | $2.49M | Sell |
1,124,435
-100,000
| -8% | -$221K | 0.31% | 79 |
|
|
2023
Q3 | $3.55M | Sell |
1,224,435
-810,000
| -40% | -$2.35M | 0.6% | 50 |
|
|
2023
Q2 | $3.93M | Sell |
2,034,435
-835,565
| -29% | -$1.61M | 0.65% | 47 |
|
|
2023
Q1 | $5.6M | Sell |
2,870,000
-927,157
| -24% | -$1.81M | 0.97% | 34 |
|
|
2022
Q4 | $4.44M | Sell |
3,797,157
-65,000
| -2% | -$76.1K | 0.8% | 42 |
|
|
2022
Q3 | $4.25M | Sell |
3,862,157
-11,746
| -0.3% | -$12.9K | 0.83% | 40 |
|
|
2022
Q2 | $6.2M | Buy |
3,873,903
+95,565
| +3% | +$153K | 1.16% | 32 |
|
|
2022
Q1 | $13.6M | Buy |
3,778,338
+263,338
| +7% | +$945K | 1.96% | 16 |
|
|
2021
Q4 | $13.8M | Buy |
3,515,000
+225,000
| +7% | +$882K | 1.73% | 18 |
|
|
2021
Q3 | $21.7M | Buy |
3,290,000
+39,750
| +1% | +$262K | 2.89% | 8 |
|
|
2021
Q2 | $20M | Buy |
3,250,250
+847,750
| +35% | +$5.22M | 2.93% | 8 |
|
|
2021
Q1 | $10.9M | Buy |
2,402,500
+1,152,500
| +92% | +$5.21M | 1.48% | 23 |
|
|
2020
Q4 | $7.5M | Buy |
1,250,000
+470,000
| +60% | +$2.82M | 1.26% | 29 |
|
|
2020
Q3 | $5.8M | Buy |
780,000
+217,500
| +39% | +$1.62M | 1.16% | 32 |
|
|
2020
Q2 | $2.26M | Buy |
+562,500
| New | +$2.26M | 0.48% | 58 |
|